International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 61-63 , April 2010

Chronic complications of diabetes mellitus in newly diagnosed patients

  • Iraj Heydari

      Affiliations

    • Institute of Endocrinology and metabolism, Iran University of Medical Sciences, Tehran, Iran
    • Professor assistant of endocrinology and metabolism.
    • ,
  • Vida Radi

      Affiliations

    • Institute of Endocrinology and metabolism, Iran University of Medical Sciences, Tehran, Iran
    • General practitioner, Iran University of Medical Sciences.
    • ,
  • Sara Razmjou

      Affiliations

    • Institute of Endocrinology and metabolism, Iran University of Medical Sciences, Tehran, Iran
    • Corresponding Author InformationCorresponding author. Present Address: Institute of Endocrinology and metabolism, Iran University of Medical Sciences, Firouzgar, hospital, Valadi street, Valiasr Square, Tehran, Iran. Tel.: +0098 91 26606701; fax: +0098 21 88942622.
    • Research fellow, medical student at Iran University of Medical Sciences.
    • ,
  • Afsaneh Amiri

      Affiliations

    • Gastrointestinal and Liver Disease Research Centre, Firouzgar hospital, Tehran, Iran
    • Research fellow, medical student at Iran University of Medical Sciences.

Received 12 July 2009 ,Accepted 31 August 2009.

References 

  1. Hovens MMC, Van de Laar FA, Cannegieter SC, Vandenbroucke JP. Acetylsalicylic acid (Aspirin) for primary prevention of cardiovascular disease in type 2 Diabetes Mellitus (protocol). Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD005446.
  2. Arinzon Z, Shabat S, Shuval I, Peisakh A, Berner Y. Prevalence of Diabetes Mellitus in elderly patients received enteral nutrition long-term care service. Arch Gerontol Geriatr. 2007;
  3. Bethel MA, Sloan FA, Belsky D, Feinglos MN. Longitudinal incidence and prevalence of adverse outcomes of Diabetes Mellitus in elderly patients. Arch Intern Med. 2007;167(9):921–927
  4. Piechowski-Jozwiak B, Maulaz A, Bogousslavsky J. Secondary prevention of stroke with antiplatelet agents in patients with Diabetes Mellitus. Cerebrovasc Dis. 2005;20(Suppl 1):15–23
  5. Spijkerman AM, Dekker JM, Nijpels G, Adriaanse MC, Kostense PJ, Ruwaard D, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes Care. 2003;26(9):2604–2608
  6. Krentz AJ, Clough G, Byrne CD. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. Diabetes Obes Metab. 2007;9(6):781–791
  7. Rosolova H, Petrlova B, Simon J, Sifalda P, Sipova I, Sefrna F. Macrovascular and microvascular complications in type 2 diabetes patients. Vnitr Lek. 2008;54(3):229–237
  8. Scheffel RS, Bortolanza D, Weber CS, Costa LA, Canani LH, Santos KG, et al. Prevalence of micro and macroangiopatic chronic complications and their risk factors in the care of out patients with type 2 diabetes mellitus. Rev Assoc Med Bras. 2004;50(3):263–267
  9. Bleyer AJ, Sedor JR, Freedman BI, O’Brien A, Russell GB, Graley J, et al. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease. Am J Kidney Dis. 2008;51(1):29–37
  10. Dyck PJ. Detection, characterization and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 1988;11:21–32
  11. Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007;9(6):767–780
  12. Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci. 2006;1084:1–29
  13. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49(7):571–576
  14. 14 . Somaratne JB, Whalley GA, Bagg W, Doughty RN. Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 Diabetes Mellitus. Expert Rev Cardiovasc Ther. 2008;6(1):109–125
  15. Harzallah F, Ncibi N, Alberti H, Ben Brahim A, Smadhi H, Kanoun F, et al. Clinical and metabolic characteristics of newly diagnosed diabetes patients: experience of a university hospital in Tunis. Diabetes Metab. 2006;32(6):632–635
  16. Weerasuriya N, Siribaddana S, Dissanayake A, Subasinghe Z, Wariyapola D, Fernando DJ. Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus. QJM. 1998;91(6):439–443
  17. Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, Parving HH. Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993;36(10):1064–1070
  18. Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM. UK Prospective Diabetes Study Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 Diabetes Mellitus: UKPDS 69. Arch Ophthalmol. 2004;122(11):1631–1640
  19. Funatsu H, Yamashita H. Pathogenesis of diabetic retinopathy and the renin-angiotensin system. Ophthalmic Physiol Opt. 2003;23(6):495–501
  20. Zander E, Heinke P, Herfurth S, Reindel J, Ostermann FE, Kerner W. Relations between diabetic retinopathy and cardiovascular neuropathy--a cross-sectional study in IDDM and NIDDM patients. Exp Clin Endocrinol Diabetes. 1997;105(6):319–322
  21. Sprafka JM, Bender AP, Jagger HG. Prevalence of hypertension and associated risk factors among diabetic individuals. The Three-City Study. Diabetes Care. 1988;11(1):17–22

PII: S1877-5934(09)00049-6

doi: 10.1016/j.ijdm.2009.08.001

International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 61-63 , April 2010

Article Tools

* Image Usage & Resolution